I'm back. Thank you for indulging my month off - spent it up north with the kids. Meanwhile, Medtronic Plc (MDT) beat profit expectations as organic sales grew 13.7%, higher than expected, writes Amber Kanwar, host of the In the Money with Amber Kanwar podcast.
I feel a bit like the person who discovered sliced bread 100 years after everyone else. I never grew up going to cottages and now I find myself telling everyone how great it is. The fresh air! The slower pace! The children outdoors - no screens!
In the markets, stocks started September deep in the red because bond markets around the world sold off. Yields are hitting new highs across the board as inflation continues to run hot globally.
(Editor’s Note: Amber will be speaking at the 2026 MoneyShow Masters Symposium Toronto, scheduled for Sept. 24-25. Click HERE to register.)
As for Medtronic, it increased its organic growth sales forecast as all divisions including cardio, surgical, and diabetes were higher than anticipated. The rub is that margins were slightly below expectations.
The stock has struggled over the past year. But it has staged a slight recovery from the lows at the beginning of the summer. It trades at 15x earnings and sports a 3% dividend yield.
